Business
Pfizer ends COVID-19 vaccine trial with 95 per cent efficacy – Sydney Morning Herald
Effectiveness of the vaccine was consistent across age and ethnicity demographics, and that there were no major side effects, a sign that the immunisation could…
The better-than-expected data from the two vaccines, both developed with new technology known as messenger RNA (mRNA), have raised hopes for an end to a resurgent pandemic that has killed more than 1.3 million people globally and wreaked havoc upon economies and daily life.
However, while some groups such as healthcare workers will be prioritised in the United States for vaccinations this year, it will be months before large-scale rollouts begin.
Pfizer said on Wednesday there had been 170 cases…
-
Noosa News12 hours agoA World-Premiere Exhibition Dedicated to Crocodiles Is Snapping Its Way Into Queensland Museum Kurilpa, Then Touring Nationally
-
General24 hours agoTrump’s military parade exposes weak Albo and Wong
-
General21 hours agoSyrian doctor guilty of torture and war crimes sentenced to life in prison
-
Noosa News13 hours agoResearchers uncover spike in potentially fatal ‘rat lungworm disease’